Kewaunee Scientific (KEQU) executive compensation, 2026 proxy

Thomas D. Hull III, President and Chief Executive Officer, was paid $2M in 2026, up 9% from $1.8M the year before.

Filed
July 7, 2026
Annual meeting
August 26, 2026
Pay year
2026
Named executives
3
CEO total pay
$2M+9% vs prior year
CEO pay in equity
51%$997,930 in awards
CEO compensation actually paid
$2,807,318Fiscal 2026 pay-versus-performance disclosure
Average non-PEO NEO total
$795,100Summary Compensation Table average
Average non-PEO NEO paid
$1,052,385Pay-versus-performance disclosure
Company shareholder return
$227.75Value of initial fixed $100 investment
Net income
$9,618Thousands, fiscal 2026

How III was paid

$2M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary27%Stock awards51%Non-equity incentive20%All other compensation2%

Named executive officers

ExecutiveTotal
Thomas D. Hull IIIPresident and Chief Executive Officer$1,965,495
Donald T. Gardner IIIVice President Finance and Chief Financial Officer$970,370
Douglas BatdorffVice President of Manufacturing Operations$619,828

What changed and why

  • $2M$1,965,495 was the CEO’s 2026 total compensation, compared with $1,811,359 in 2025.
  • $998K$997,930 of CEO compensation was stock awards, including performance-based RSUs tied to financial measures.
  • $395K$394,967 was the CEO’s annual incentive plan compensation for 2026.
  • $150K$150,000 was CFO Donald Gardner’s retention bonus in 2025, subject to forfeiture through June 26, 2027.
  • EBITDA targets determine attainment of the financial component of three-year performance-based RSU awards.
  • $2.8M$2,807,318 was the CEO’s 2026 compensation actually paid under pay-versus-performance disclosure rules.

Other Kewaunee Scientific proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.